Lv3
330 积分 2025-02-04 加入
The adenosine pathway in immuno-oncology
2天前
已完结
Overcoming solid-tumor barriers: armored CAR-T cell therapy
29天前
已完结
Synthetic cytokine circuit targets solid tumours
29天前
已完结
CAR T cell immunotherapy for human cancer
30天前
已完结
Programmable Smart CAR-T design: A new paradigm in precision immunotherapy driven by logic gates, conditional activation, allogeneic strategies, and artificial intelligence
30天前
已完结
Antigen escape in CAR ‐T therapy: A tumor microenvironment perspective from hematological to solid tumors
1个月前
已完结
Current understanding and management of CAR T cell-associated toxicities
1个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
1个月前
已完结
Metabolic challenges and interventions in CAR T cell therapy
2个月前
已完结
Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancer
2个月前
已完结
皖公网安备34019202002308
